767 related articles for article (PubMed ID: 18440921)
1. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.
Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM
Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study.
Staahl C; Dimcevski G; Andersen SD; Thorsgaard N; Christrup LL; Arendt-Nielsen L; Drewes AM
Scand J Gastroenterol; 2007 Mar; 42(3):383-90. PubMed ID: 17354119
[TBL] [Abstract][Full Text] [Related]
4. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
7. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600
[TBL] [Abstract][Full Text] [Related]
8. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview.
Ing Lorenzini K; Daali Y; Dayer P; Desmeules J
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):219-26. PubMed ID: 21995512
[TBL] [Abstract][Full Text] [Related]
10. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
Miner JR; Moore J; Gray RO; Skinner L; Biros MH
Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
[TBL] [Abstract][Full Text] [Related]
11. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
[TBL] [Abstract][Full Text] [Related]
12. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
Boström E; Hammarlund-Udenaes M; Simonsson US
Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
[TBL] [Abstract][Full Text] [Related]
14. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine.
Beaver WT; Wallenstein SL; Rogers A; Houde RW
J Pharmacol Exp Ther; 1978 Oct; 207(1):101-8. PubMed ID: 359778
[TBL] [Abstract][Full Text] [Related]
15. Oral oxycodone: new preparation. No better than oral morphine.
Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
[TBL] [Abstract][Full Text] [Related]
16. Reduction of human experimental muscle pain by alfentanil and morphine.
Schulte H; Segerdahl M; Graven-Nielsen T; Grass S
Eur J Pain; 2006 Nov; 10(8):733-41. PubMed ID: 16414295
[TBL] [Abstract][Full Text] [Related]
17. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
[TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesia.
Olesen AE; Upton R; Foster DJ; Staahl C; Christrup LL; Arendt-Nielsen L; Drewes AM
Clin Pharmacokinet; 2010 Dec; 49(12):817-27. PubMed ID: 20873879
[TBL] [Abstract][Full Text] [Related]
19. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy.
Davis MP; Varga J; Dickerson D; Walsh D; LeGrand SB; Lagman R
Support Care Cancer; 2003 Feb; 11(2):84-92. PubMed ID: 12560936
[TBL] [Abstract][Full Text] [Related]
20. Revisiting Oxycodone Analgesia: A Review and Hypothesis.
Ruan X; Mancuso KF; Kaye AD
Anesthesiol Clin; 2017 Jun; 35(2):e163-e174. PubMed ID: 28526158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]